Lake Ronkonkoma, NY, United States of America

Bhaskar Reddy Kusuma

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of Kansas. Active years: 2015-2026.


% Patents Active = 87.5


 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Lawrence, KS (US) (2015 - 2016)
  • Lake Ronkonkoma, NY (US) (2018 - 2024)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Bhaskar Reddy Kusuma: Innovator in Neurodegenerative Disorder Treatments

Introduction

Bhaskar Reddy Kusuma is a prominent inventor based in Lake Ronkonkoma, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. With a total of seven patents to his name, Kusuma's work is paving the way for innovative therapies.

Latest Patents

Kusuma's latest patents focus on C-terminal HSP90 inhibitors. These Hsp90 C-terminal inhibitors and the pharmaceutical compositions containing such compounds are designed to treat and prevent neurodegenerative disorders, including diabetic peripheral neuropathy. His research emphasizes the importance of these compounds in advancing medical treatments.

Career Highlights

Kusuma is affiliated with the University of Kansas Medical Center Research Institute, where he conducts his research. His work has garnered attention for its potential impact on the treatment of debilitating conditions that affect millions of people worldwide.

Collaborations

Some of his notable coworkers include Brian S J Blagg and Teather Sundstrom. Their collaborative efforts contribute to the innovative research being conducted in the field of neurodegenerative disorders.

Conclusion

Bhaskar Reddy Kusuma's contributions to the field of pharmaceuticals, particularly through his patents on C-terminal HSP90 inhibitors, highlight his role as a key innovator in the treatment of neurodegenerative disorders. His work continues to inspire advancements in medical research and therapy development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…